HBT Financial HBT 深 沪
已收盘 07-02 16:00:00 美东时间
32.18
-0.560
-1.71%
华盛通- 最 高33.095
- 今 开32.86
- 成交量 12.25万股
- 最 低 32.02
- 昨 收 32.74
- 总市值 11.71亿
- 52周最高 33.095
- 市盈率 静 13.21
- 换手率 0.34%
- 52周最低 21.6901
- 委 比 38.41%
- 总股本 3638.11万
- 历史最高 33.095
- 量 比 0.33
- 振 幅 3.28%
- 历史最低 4.68
- 每 手 1
- 风险率 2.10%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 潜在涨幅90.66%！Tango Therapeutics获杰富瑞升目标价至60美元，上调至"买入"评级
今日重点评级关注：杰富瑞：上调Tango Therapeutics评级至"买入"，目标价从27美元升至60美元；Susquehanna：维持安森美半导体"积极"评级，目标价从120美元升至140美元
06-29 15:49
Piper Sandler Maintains Neutral on HBT Finl, Raises Price Target to $34
Piper Sandler analyst Nathan Race maintains HBT Finl (NASDAQ:HBT) with a Neutral and raises the price target from $32 to $34.
06-26 22:53
美股大行评级 | 达美乐比萨惨遭10家大行下调目标价；铿腾电子、艾克尔科技、Relay 、辛普森配件制造、TFI International等获多家大行上调目标价
今日重点评级关注：Canaccord Genuity：维持Intellia Therapeutics"买入"评级，目标价从48美元升至58美元；富国银行：维持曼恩凯德生物医疗"超配"评级，目标价从7美元升至8美元
04-29 10:28
Piper Sandler Maintains Neutral on HBT Finl, Raises Price Target to $32
Piper Sandler analyst Nathan Race maintains HBT Finl (NASDAQ:HBT) with a Neutral and raises the price target from $30 to $32.
04-28 22:48
Earnings Scheduled For April 27, 2026
Companies Reporting Before The Bell • Alliance Res Partners (NASDAQ:ARLP) is es...
04-27 19:11
HBT Finl Q1 Adj. EPS $0.68 Beats $0.61 Estimate, Sales $67.331M Beat $66.717M Estimate
HBT Finl (NASDAQ:HBT) reported quarterly earnings of $0.68 per share which beat the analyst consensus estimate of $0.61 by 11.48 percent. This is a 11.48 percent increase over earnings of $0.61 per share from the same
04-27 19:07
HBT Financial, Inc. Announces Addition to Board of Directors
HBT Financial, Inc. announced the appointment of Michael J. Morton to its Board of Directors and Heartland Bank's board, effective April 1, 2026. Morton, with nearly 40 years of banking experience, previously served as Vice Chair of U.S. Commercial Banking at BMO and Executive Vice President and Chief Credit Officer at MB Financial. Fred L. Drake, Executive Chairman, expressed confidence in Morton's leadership and expertise to contribute to the c...
03-25 11:05
美股大行评级 | 韦德布什升美光科技目标价升至500美元，维持"跑赢大市"评级
今日重点评级关注：Piper Sandler：维持Allogene疗法"超配"评级，目标价从7美元升至8美元；B. Riley证券：维持Oncology Institute"买入"评级，目标价从6美元升至8美元
03-16 18:19
Piper Sandler Maintains Neutral on HBT Finl, Raises Price Target to $30
Piper Sandler analyst Nathan Race maintains HBT Finl (NASDAQ:HBT) with a Neutral and raises the price target from $29 to $30.
03-14 00:21
